AbbVie Inc.
METHODS FOR TREATING RELAPSING FORMS OF MULTIPLE SCLEROSIS

Abstract:

Disclosed herein are anti-RGMa antibodies and methods of using these antibodies to treat multiple sclerosis, including relapsing forms of multiple sclerosis such as relapsing-remitting multiple sclerosis or relapsing-secondary progressive multiple sclerosis.